Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin?

Systems Biology in Reproductive Medicine
V S BaranovMaria I Yarmolinskaya

Abstract

Endometriosis (EM) and uterine leiomyoma (UL) are two most frequent benign tumors of monoclonal origin affecting about 30% of all women in their reproductive age. Modern molecular technologies have made a tremendous impact in understanding both disorders. Here is the first comparative analysis of molecular mechanisms underlying development of EM and UL as it looks from the platform of systems genetics. Similarities and differences of EM and UL at their incipient stages are enlightened with special emphasis on their gene networks, gene expression, and epigenetic regulation, of pathologic development. The analysis substantiates a new hypothesis postulating tumors as outgrowths of the stem cells with mesenchymal commitment lineage (mSC) which migrate from the endometrium/myometrium junctional zone of the uterus. Comparative analysis has revealed basic similarities of molecular pathogenesis of EM and UL suggesting molecular syntropy of both disorders. Peculiarities of the epigenetic landscape determining development of mSC may explain the existence of different clinical forms of EM and UL as well as their unique clinical manifestation. Some perspectives for practical and scientific application in EM and UL studies of this new hypot...Continue Reading

References

Jan 1, 1991·Annals of the New York Academy of Sciences·H A Padykula
Mar 5, 1998·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·J FujimotoT Tamaya
Jun 9, 2001·Current Opinion in Obstetrics & Gynecology·K T ZondervanS H Kennedy
Jun 4, 2002·Human Reproduction·Krina T ZondervanStephen H Kennedy
Jun 14, 2002·Journal of Reproductive Immunology·Farideh Z BischoffJoe Leigh Simpson
Feb 10, 2004·Biology of Reproduction·Rachel W S ChanCaroline E Gargett
Jul 9, 2004·Fertility and Sterility·Aude BéliardJean-Michel Foidart
Mar 28, 2006·The Journal of Biological Chemistry·Seokjoong KimThomas G Boyer
Apr 26, 2006·American Journal of Obstetrics and Gynecology·Phyllis C LeppertJames H Segars
Sep 4, 2007·Fertility and Sterility·Erica E MarshSerdar E Bulun
Apr 30, 2008·Annals of the New York Academy of Sciences·Isaac E Sasson, Hugh S Taylor
Jun 7, 2008·Best Practice & Research. Clinical Obstetrics & Gynaecology·Stanley Okolo
Aug 7, 2008·Reproductive Biomedicine Online·Angelo TocciFilippo Maria Ubaldi
Dec 6, 2008·The Prostate·Paula SotomayorWendy J Huss
Feb 17, 2009·Molecular Human Reproduction·Yoshiaki YamagataNorihiro Sugino
Jun 3, 2009·The Journal of Clinical Investigation·Raghu Kalluri
Jun 6, 2009·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Zhao Ying, Zhang Weiyuan
Dec 1, 2009·Cell·Jean Paul ThieryM Angela Nieto
Apr 24, 2010·Seminars in Reproductive Medicine·Minnie MalikWilliam H Catherino
May 11, 2010·Fertility and Sterility·Shannon K LaughlinDonna D Baird
Oct 5, 2010·The International Journal of Biochemistry & Cell Biology·Juan SuYi-Ping Hu
Jun 16, 2011·Molecular and Cellular Endocrinology·J Julie Kim, Elizabeth C Sefton
Jul 8, 2011·European Journal of Obstetrics, Gynecology, and Reproductive Biology·S B LarsenM Dueholm
Oct 11, 2011·Matrix Biology : Journal of the International Society for Matrix Biology·John M NorianJames H Segars
Mar 2, 2012·Gynecologic and Obstetric Investigation·Anelise Olmos GringsEdison Capp
May 10, 2012·PloS One·Masanori OnoSerdar E Bulun
Jul 24, 2012·Fertility and Sterility·Richard O Burney, Linda C Giudice
Jan 8, 2013·Fertility and Sterility·Jui-Hung ChangChii-Ruey Tzeng
Jan 31, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Swati SuryawanshiXin Huang
May 10, 2013·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Wenqing YangRu Li
Aug 6, 2013·International Journal of Cancer. Journal International Du Cancer·Netta MäkinenLauri A Aaltonen
Aug 29, 2013·Molecular Human Reproduction·G W MontgomeryD R Nyholt
Oct 1, 2013·Human Reproduction Update·Reshef Tal, James H Segars
Oct 4, 2013·The New England Journal of Medicine·Serdar E Bulun
Oct 29, 2013·Obstetrics and Gynecology International·Andrea CiavattiniPasquapina Ciarmela
Jan 1, 2014·Human Immunology·Hiroshi KobayashiYuki Yamada
Jan 7, 2014·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Elizabeth BertschJian-Jun Wei

❮ Previous
Next ❯

Citations

Jun 26, 2018·International Journal of Molecular Sciences·Vladislav BaranovMaria Yarmolinskaya
Dec 11, 2019·International Journal of Molecular Sciences·Vladislav S BaranovMaria I Yarmolinskaya

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.